AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
The Dual Edge of GLP-1 Drugs
This chapter examines the effects of GLP-1 drugs like Ozempic on weight control and behavioral changes, such as reduced cravings. It also addresses concerns about muscle loss and the commitment required for long-term use of these medications, particularly in the context of obesity in America. The discussion highlights the potential for advancements in therapies focusing on muscle retention amidst the weight loss facilitated by these drugs.